The Trinity Biotech Uni-Gold™ Strep A test kit is intended for the rapid, in vitro qualitative detection of group A Streptococcal antigen from human throat swabs. It can also be used as a confirmation test of beta-haemolytic colonies obtained from blood agar plates. The test is intended for professional use in physicians offices as an aid in the rapid diagnosis of group A Streptococcal pharyngitis. The test may also be used in hospital laboratories as an aid in the rapid diagnosis of group A Streptococcal pharyngitis and the confirmation of group A Streptococcus from culture.
Device Story
Lateral flow immunoassay for qualitative detection of group A Streptococcal antigen. Input: human throat swab specimens or beta-haemolytic colonies from blood agar plates. Operation: extracted sample flows through absorbent pad containing anti-Strep A antibody conjugated to colloidal gold; antigen-antibody complex forms if antigen present; complex migrates to membrane test region impregnated with rabbit polyclonal anti-Strep A antibody, forming visible pink/red line. Control line indicates proper test function. Used in physician offices and hospital laboratories by professional staff. Output: visual qualitative result (presence/absence of pink/red test line). Assists clinicians in rapid diagnosis of group A Streptococcal pharyngitis and confirmation of culture results.
Clinical Evidence
Clinical study of 501 fresh throat samples compared Uni-Gold Strep A to routine culture. Results showed 97.0% overall agreement. Relative sensitivity 99.0% (97/98) and relative specificity 99.3% (400/403) when discordant results were resolved against culture. Additional confirmation study of 224 samples demonstrated 98.1% sensitivity compared to Streptococcal latex grouping test.
Indicated for professional use in physician offices and hospital laboratories for the rapid, in vitro qualitative detection of group A Streptococcal antigen from human throat swabs and confirmation of beta-haemolytic colonies from blood agar plates as an aid in the diagnosis of group A Streptococcal pharyngitis.
Regulatory Classification
Identification
Streptococcus spp. serological reagents are devices that consist of antigens and antisera (excluding streptococcal exoenzyme reagents made from enzymes secreted by streptococci) used in serological tests to identify Streptococcus spp. from cultured isolates derived from clinical specimens. The identification aids in the diagnosis of diseases caused by bacteria belonging to the genus Streptococcus and provides epidemiological information on these diseases. Pathogenic streptococci are associated with infections, such as sore throat, impetigo (an infection characterized by small pustules on the skin), urinary tract infections, rheumatic fever, and kidney disease.
Predicate Devices
Quidel Quick Vue® In-line One-Step Strep A Test
Submission Summary (Full Text)
{0}------------------------------------------------
NOV 0 82001
# KO117
## 510(k) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92
The assigned 510(k) number is K 011709.
| Submitter Information (21 CFR 807.92 (a) (1)) | |
|-----------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------|
| Submitter: | Trinity Biotech, plc<br>IDA Business Park<br>Bray<br>Co. Wicklow<br>Ireland |
| Contact: | Fiona Campbell<br>Regulatory Affairs Manager<br>Trinity Biotech, plc<br>Phone: 011 353 2769800<br>Fax: 011 353 2769888 |
| Summary Date: | May 30, 2001 |
| Name of Device and Classification (21 CFR 807.92 (a) (2)) | |
| Name (trade): | Uni-GoldTM Strep A test kit |
| Name (usual): | Streptococcus spp. serological reagents |
| Classification: | 21 CFR 866.3740, Class 1, GTZ |
## Identification of Legally Marketed Predicate Device(s) (21 CFR 807.92 (a) (3))
The Uni-Gold™ Strep A test kit is substantially equivalent to the Quidel Quick Vue® In-line One-Step Strep A Test (Quidel Corporation, 10165 McKellar Court, San minne CA 92121). The Uni-Gold™ Strep A test kit is identical, or similar to, its predicate device in terms of : antigen detection, technology/methodology, testing matrix, result interpretation, and clinical performance.
{1}------------------------------------------------
#### Description of Device (21 CFR 807.92 (a) (4))
The extracted sample flows through an absorbent pad containing anti-Strep A antibody conjugated to colloidal gold which binds group A Streptoccal antigen if present, forming an antigen-antibody complex. As this complex travels along the membrane, it becomes immobilised at the test region, which is impregnated with a rabbit polyclonal anti-Strep A antibody, resulting in the formation of a pink/red line. A pink/red line will also appear in the control region of the test indicating proper functioning of the test. In the absence of group A Streptococcal antigen, a pink/red line will only appear in the control line.
#### Intended Use 21 CFR 807.92 (a) (5))
The Trinity Biotech Uni-Gold™ Strep A test kit is intended for the rapid, in vitro qualitative detection of group A Streptococcal antigen from human throat swabs. It can also be used as a confirmation test of beta-haemolytic colonies obtained from blood agar plates. The test is intended for professional use in physicians offices as an aid in the rapid diagnosis of group A Streptococcal pharyngitis. The test may also be used in hospital laboratories as an aid in the rapid diagnosis of group A Streptococcal pharyngitis and the confirmation of group A Streptococcus from culture.
#### Similarities to the Predicate(s) (21 CFR 807.92 (a) (6))
A summary of the similarities and differences between the Uni-Gold™ Strep A test kit and the predicate device follows.
{2}------------------------------------------------
| Characteristics | Uni-GoldTM Strep A | Predicate device |
|-------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | Intended for the rapid, in vitro<br>qualitative detection of group A<br>Streptococcal antigen from human<br>throat swabs. It can also be used as<br>a confirmation of beta-haemolytic<br>colonies obtained from blood agar<br>plates. The test is intended for<br>professional use in physicians'<br>offices and hospital laboratories as<br>an aid in the diagnosis and<br>confirmation of group A<br>Streptococcal pharyngitis. | Allows for the rapid detection of<br>group A streptococcal antigen<br>directly from patient throat swab<br>specimens. The test is intended<br>for use as an aid in the diagnosis<br>of group A Streptococcal<br>infection. |
| Methodology | Immunoassay | Immunoassay |
| Antigen<br>Detected | Group A Strep | Group A Strep |
| Type of Test | Qualitative | Qualitative |
| Principle of the<br>Test | The extracted sample flows<br>through an absorbent pad<br>containing anti-Strep A antibody<br>conjugated to colloidal gold which<br>binds group A Streptococcal<br>antigen if present, forming an<br>antigen-antibody complex. As this<br>complex travels along the<br>membrane, it becomes<br>immobilised at the test region,<br>which is impregnated with a rabbit<br>polyclonal anti-Strep A antibody,<br>resulting in the formation of a<br>pink/red line. A pink/red line will<br>also appear in the control region of<br>the test indicating proper<br>functioning of the test. In the<br>absence of group A Streptococcal<br>antigen, a pink/red line will only<br>appear in the control line. | The extracted sample migrates<br>through a label pad consisting of<br>a pink label containing rabbit<br>polyclonal anti-Strep A antibody<br>and a blue control label. If the<br>extracted solution contains Strep<br>A antigen, the antigen will bind<br>to the antibody on the pink test<br>label which, in turn, will bind a<br>second rabbit polyclonal anti-<br>Strep A antibody spotted on the<br>membrane, resulting in the<br>formation of a pink-to-purple<br>Test line. A blue Control line<br>will also appear next to the letter<br>"C" on the test cassette<br>indicating proper functioning of<br>the test. If Strep A is not present<br>or present at very low levels,<br>only a blue Control line will be<br>visible. |
| Characteristics | Uni-Gold TM Strep A | Predicate device |
| Materials<br>required but<br>not supplied | Timer or Stopwatch<br>Tongue depressor<br>Gloves | Timer<br>Tongue blade or spoon<br>Gloves |
| Test Matrix/<br>Specimen type | Throat swab | Throat swab |
| Specimen<br>Collection and<br>Preparation | Use only swabs provided. Collect<br>throat swab specimens using<br>standard throat swab collection<br>methods. Depress the tongue with<br>a tongue depressor. Be careful not<br>to touch the teeth, tongue, sides or<br>top of the mouth with the swab.<br>Rub a sterile swab on the posterior<br>pharynx, tonsils and inflamed<br>areas. Process specimen samples<br>as soon as possible after<br>collection. Swabs can be held in a<br>clean, dry paper sleeve at 15-30°C<br>for up to 4 hours or at 2-8°C for up<br>to 24 hours before processing. | Use only swabs provided.<br>Collect throat swab specimens<br>by standard clinical methods.<br>Depress the tongue with a<br>tongue blade or spoon. Be<br>careful not to touch the tongue,<br>sides or top of the mouth with<br>the swab. Rub the swab on the<br>back of the throat, on the tonsils,<br>and in any other area where there<br>is redness, inflammation or pus.<br>Process specimen samples as<br>soon as possible after collection.<br>Swabs can be held in any clean,<br>dry plastic tube or sleeve at 15-<br>30°C for up to 4 hours or 24<br>hours refrigerated (2-8°C) before<br>processing. |
| Controls<br>provided | 1 Positive control vial and 1<br>Negative control vial | 1 Positive control swab and 1<br>Negative control swab |
| Extraction<br>Buffers | 2 | 2 |
| Assay Read<br>Time | 5 minutes | 5 minutes |
| Result<br>Interpretation | Positive or Negative for Strep A<br>antigen | Positive or Negative for Strep A<br>antigen |
| Stability of<br>Results | Results should be read after 5<br>minutes | Results should be read after 5<br>minutes |
| CLIA Waived | To be requested | Yes |
| Characteristics | Uni-Gold TM Strep A | Predicate device |
| Re Use of Kit Controls | Yes. Controls are supplied<br>enough for multiple tests | No. Only 1 positive and 1<br>negative control swab supplied<br>each for single use only |
| Extraction Time | 3 minutes | none |
| Storage<br>Temperature | 2-27°C (entire kit) | 15-30°C (entire kit) |
## Similarities Between Uni-Gold™ Strep A test kit and Predicate Device
{3}------------------------------------------------
## Similarities Between Uni-Gold™ Strep A test kit and Predicate Device (Continued)
## Differences Between Uni-Gold™ Strep A test kit and Predicate Device
{4}------------------------------------------------
## Brief Discussion of Nonclinical Data (21 CFR 807.92 (b) (1))
Differ Discussion of Nore conducted to evaluate analytical sensitivity (lowest limit of Laboratory studies were contacted rross-reactivity testing from potential interferents). Summary description and results from those studies are provided below.
#### Analytical Sensitivity
Analytical Sensitivity
Serial dilutions were prepared from two cultures of group A Streptococcus, and were tested with the Uni-Gold™ Strep A test kit until the interpretations became "negative".
The results indicate that the lowest level of detection of the Uni-Gold™ Strep A test kit is 1 x 105 cells per swab.
#### Analytical Specificity
The Uni-Gold™ Strep A test kit was used to test a variety of organisms at The Uni Ook - Survimately 1 x 10' cells per swab. Negative results were obtained in all cases.
## Brief Discussion of Clinical Data (21 CFR 807.92 (b) (2))
#### Accuracy
Accuracy of the Trinity Biotech Uni-Gold™ Strep A test kit was determined through the analysis of 501 fresh throat samples tested both in the immunoassay and by routine culture.
The results from comparative testing between Uni-Gold™ vs. routine culture are presented below.
| n = 501 samples | | Routine | Culture |
|--------------------|---|---------|---------|
| | | + | - |
| Uni-GoldTM Strep A | + | 97 | 3 |
| | - | 12 | 389 |
| Reference Totals | | 109 | 392 |
## Uni-Gold™ Strep A Test Kit Results vs. Routine Culture Results
{5}------------------------------------------------
The data indicated the Uni-Gold™ Strep A test kit correctly identified 97 of 109 The data indicated the Cin Com Com 30.0% and correctly identified 389 of 992 negative positive rosults for a sensions - The overall agreement between Uni-Gold™ Strep A test kit and routine culture was 97.0% (486/501). These data demonstrate good agreement between the two methods.
#### Uni-Gold™ Strep A vs predicate device
The results from the direct comparison of the two immunoassays are presented below.
| | Uni-GoldTM | Predicate device | Number | Percent of<br>Total |
|---------------------------|------------|------------------|--------|---------------------|
| Concordant Results | + | + | 86 | |
| | - | - | 398 | 96.6% |
| Discordant Results | + | - | 14 | |
| | - | + | 3 | 3.4% |
| Total Specimens<br>Tested | | | 501 | 100% |
Concordance results between Uni-Gold™ Strep A and Predicate device
Good agreement was observed between the Uni-Gold™ Strep A test kit and predicate device. There was positive concordance in 96.6% of samples (86/89), and negative device. There was possfar oles (398/412). Overall concordance was seen in 96.6% of the samples (484/501).
#### Culture Confirmation
The Uni-Gold ™ Strep A test kit was used to confirm the identification of group A The Onl-Ood agar plates. Samples that were visually positive on the culture assay Surp on blood agar places. Danples A test kit and a Streptococcal latex grouping test kit as the predicate to confirm a positive result.
The Uni-Gold TM Strep A test kit correctly identified 105/109 samples as group A The Only - Burepensitivity of 96.3%. 2 of the 4 samples positive for Strep A on Streplococcus giving a sensitivity of 70.57%. 2 or the Feat. kit were identified by the Culture but negative by ag est as mixed cultures containing group A Streptococcus. Streplococcal lates grouping tost as immed canasative by the Uni-Gold ™ Strep A test kit were identified as non group A Streptococcus (group B Streptococcus and a mixed kil were ficmined as non group F Streptococcus) . Thus, the Uni-Gold TM Strep A test kit
{6}------------------------------------------------
correctly identified 105/107 samples as group A Streptococcus giving a sensitivity of 98.1% as compared against a Streptococcal latex grouping test.
In a further study of 224 samples, 117 of these were identified as non- Strep A colonies by morphology and the absence of beta-haemolysis. These were tested on the Uni-Gold The Strep A test where all negative samples were correctly identified. The results are summarized in the table below.
| n = 224 samples | | Strep A Culture (confirmed by Beta-<br>haemolysis and morphology) | |
|-------------------|---|-------------------------------------------------------------------|-----|
| | | + | - |
| Uni-Gold™ Strep A | + | 105 | 0 |
| | - | 2 | 117 |
| Reference Totals | | 107 | 117 |
Culture Confirmation Study
In a separate study, colonies of 2 group A beta-haemolytic organisms and 4 non group A beta-haemolytic organisms were tested in duplicate in a blinded manner by 2 independent physicians. Correct results were obtained in all cases.
#### Performance Data - Conclusions (21 CFR 807.92 (b) (3))
Analytical sensitivity of the Uni-Gold™ Strep A test kit was determined to be 1 x 100 cells per swab as demonstrated by the testing of serial dilutions in the assay. Analytical specificity testing demonstrated no interference by other organisms (pathological and nonpathological) routinely found in the throat.
The Uni-Gold™ Strep A test kit and the predicate device, with discordant results resolved against culture, revealed a relative sensitivity of Uni-Gold™ Strep A test kit of 99.0% (97/98 positive results) and a relative specificity of 99.3% (400/403 negative results). The relative overall agreement was 99.2% (497/501).
{7}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/7/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, superimposed over three horizontal lines. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" is arranged in a circular fashion around the eagle.
Public Health Service
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
NOV 0 82001
Ms. Fiona Campbell Regulatory Affairs Manager Trinity Biotech, plc IDA Business Park Bray, Co. Wicklow Ireland
Re: K011709
Trade/Device Name: Trinity Biotech Uni-Gold™ Strep A Test Kit Regulation Number: 21 CFR 866.3740 Regulation Name: Streptococcus spp. Serological Reagents Regulatory Class: I Product Code: GTY Dated: August 17, 2001 Received: August 22, 2001
Dear Ms. Campbell:
We have reviewed your Section 510(k) notification of intent to market the device referenced we have love have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device mendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to 1 coolar 1 ood, Dreg, and sions of the Act. The general controls provisions of the Act include the general octin annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations ( Femanover device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through Praction GMP inspections, the Food and Drug Administration (FDA) will verify such periodio Oril miliposmossions with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal addition, I Drimary texthis response to your premarket notification submission does not affect reefister. Freason wight have under sections 531 through 542 of the Act for devices under the any obtigation you thegation
Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{8}------------------------------------------------
Page 2 -
This letter will allow you to begin marketing your device as described in your 510(k) prematice I his letter will allow you to ocen maneting your device to a legally marketed notification. The FDA inding of succeantal equit data. Thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (2) CFR Part 801 and If you desire specific advice for your do rices), please contact the Office of Compliance at additionally 809.10 for in the diagnotions on the promotion and advertising of your device, (301) 394-4588. Additionally, for quest. It (1) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general entitled, "Wisoraliding by relevelled to premained from the Division of Small
information on your responsibilities under the Act may be obtained from the 1800 632, 2011 and information on your responsionals and Consumer Assistance at its toll-free number (800) 638-2041 or Manufacturers International and Colliberties "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Steven Butman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{9}------------------------------------------------
NOV 0 82001
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Trinity Biotech Uni-Gold™ Strep A test kit Device Name: _________________________________________________________________________________________________________________________________________________________________
Indications for Use:
The Trinity Biotech Uni-Gold™ Strep A test kit is intended for the rapid, in vitro qualitative detection of group A Streptococcal antigen from human throat swabs. It can also De used as a confirmation test of beta-haemolytic colonies obtained from blood agar plates. The test is intended for professional use in physicians offices as an aid in the rapid diagnosis of group A Streptococcal pharyngitis. The test may also be used in hospital laboratories as an aid in the may also of group A Streptococcal pharyngitis and the confirmation of group A Streptococcus from culture.
#### (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurence of CDRH, Office of Device Evaulation (ODE)
| Prescription use | <span style="text-decoration: underline;">✓</span> | Or | Over the counter Use | <span style="text-decoration: underline;">____</span> |
|----------------------|----------------------------------------------------|----|----------------------|-------------------------------------------------------|
| (per 21 CFR 801.109) | | | | (Optional Format 3-10-98) |
Luddi lu-Cook
(Division Sign-Off)
Division of Clinical Laboratory Devices
| 510(k) Number | <span style="text-decoration: underline;">K011709/51</span> |
|---------------|-------------------------------------------------------------|
|---------------|-------------------------------------------------------------|
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.